Cytogen, Inc. (KOSDAQ: 217330)
South Korea
· Delayed Price · Currency is KRW 6,820.00
+50.00 (0.74%)
Sep 11, 2024, 2:52 PM KST
Cytogen Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -15,873 | -15,770 | -18,771 | -10,871 |
| Depreciation & Amortization | 1,814 | 1,912 | 1,314 | 1,114 |
| Loss (Gain) From Sale of Assets | 79.33 | 79.33 | 0 | 0 |
| Asset Writedown & Restructuring Costs | 3,175 | 3,164 | - | - |
| Loss (Gain) From Sale of Investments | 1,570 | 1,412 | -139.47 | -472.78 |
| Stock-Based Compensation | 1,819 | 1,866 | 2,806 | 5,453 |
| Provision & Write-off of Bad Debts | 241.43 | 153.49 | 2.88 | - |
| Other Operating Activities | -338.06 | 96.49 | 8,785 | -493.66 |
| Change in Accounts Receivable | -663.61 | -11.91 | -235.79 | 473.7 |
| Change in Inventory | -181.75 | 33.25 | -131.47 | - |
| Change in Accounts Payable | 509.58 | 17.14 | 35.37 | 45.54 |
| Change in Other Net Operating Assets | -730.17 | -545.32 | -43.44 | -479.02 |
| Operating Cash Flow | -8,579 | -7,594 | -6,379 | -5,230 |
| Capital Expenditures | -638.72 | -2,498 | -645.8 | -1,219 |
| Sale of Property, Plant & Equipment | 78.94 | 78.94 | - | 0.76 |
| Cash Acquisitions | - | - | -9,561 | - |
| Sale (Purchase) of Intangibles | 174.43 | 175.58 | -99.24 | -777.85 |
| Investment in Securities | -22,615 | 2,385 | 3,592 | -4,030 |
| Other Investing Activities | -717 | 121.52 | 60.59 | 140.93 |
| Investing Cash Flow | -23,717 | 263.39 | -6,654 | -5,585 |
| Short-Term Debt Issued | - | 3,083 | - | - |
| Long-Term Debt Issued | - | 17,934 | - | 30,000 |
| Total Debt Issued | 30,683 | 21,017 | - | 30,000 |
| Short-Term Debt Repaid | - | -2,571 | - | - |
| Long-Term Debt Repaid | - | -11,840 | -493.12 | -426.55 |
| Total Debt Repaid | -17,458 | -14,411 | -493.12 | -426.55 |
| Net Debt Issued (Repaid) | 13,225 | 6,606 | -493.12 | 29,573 |
| Issuance of Common Stock | 40,000 | 40,000 | 1,119 | 409.95 |
| Other Financing Activities | 8.7 | -369.5 | -1,665 | 43.29 |
| Financing Cash Flow | 53,234 | 46,236 | -1,039 | 30,027 |
| Foreign Exchange Rate Adjustments | -95.97 | 53.61 | -338.4 | - |
| Miscellaneous Cash Flow Adjustments | - | - | - | -0 |
| Net Cash Flow | 20,842 | 38,960 | -14,410 | 19,212 |
| Free Cash Flow | -9,218 | -10,092 | -7,024 | -6,449 |
| Free Cash Flow Margin | -259.39% | -316.91% | -923.33% | -1853.87% |
| Free Cash Flow Per Share | -449.36 | -551.82 | -397.69 | -380.57 |
| Cash Interest Paid | 20.5 | 16.8 | - | - |
| Cash Income Tax Paid | 55.34 | -44.57 | 21.79 | -23.61 |
| Levered Free Cash Flow | -11,420 | -13,734 | 4,146 | - |
| Unlevered Free Cash Flow | -10,165 | -11,836 | 6,599 | - |
| Change in Net Working Capital | 4,700 | 5,135 | -10,948 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.